Einloggen
Einloggen
Oder einloggen mit
GoogleGoogle
Apple Apple     
Registrieren
Oder einloggen mit
GoogleGoogle
Apple Apple     

Business Leaders

HomeAlle NachrichtenMeistgelesene ArtikelBusiness Leaders Biografien 
Portrait de Jeffrey S. Aronin
Alter : 54
Verm÷gen : 1 593 969 USD
Gr÷▀te Unternehmen : Discover Financial Services - Harmony Biosciences Holdings, Inc.
▄bersicht 
Jeffrey S. Aronin is an entrepreneur and businessperson who founded 11 companies, among them: Harmony Biosciences Holdings, Inc., OVATION Pharmaceuticals, Inc. and Paragon Biosciences LLC and who has been the head of 12 different companies. Presently, Mr. Aronin occupies the position of Chairman & Chief Executive Officer of Paragon Pharmaceuticals Capital LLC, Chairman of Innovation Development Institute, Inc., Non-Executive Chairman for Harmony Biosciences Holdings, Inc. (which he founded in 2017), Chairman & Chief Executive Officer at Paragon Biosciences LLC (which he founded in 2010), Chairman at Paragon Health Capital LLC (which he founded in 2019) (a subsidiary of Paragon Biosciences LLC), Chairman & Chief Executive Officer of Emalex Biosciences, Inc. (which he founded), Chairman for Castle Creek Biosciences, Inc. (which he founded in 2018), Executive Chairman at Evozyne Inc (which he founded) and Director & Manager at Paragon Biosciences Skyline Capital LLC. Jeffrey S. Aronin is also on the board of 12 other companies.

He previously was Chairman & Chief Executive Officer of Marathon Pharmaceuticals LLC, Special Advisor at Merrick Ventures LLC, Chairman & Chief Executive Officer for Enterprise Technologies, Inc., President & Chief Executive Officer for OVATION Pharmaceuticals, Inc. (he founded the company in 2000), President & Chief Executive Officer for Lundbeck, Inc. (he founded the company in 2000) and Vice President-Marketing & Business Development at American Health Products Corp.

He received an undergraduate degree from Northern Illinois University and an MBA from DePaul University.


Aktuelle Stellungen und Verantwortungsbereiche Jeffrey S. Aronin 
NameTitel Seit
Discover Financial Services
(Banken)
Independent Director 2007
Harmony Biosciences Holdings, Inc.
(Pharmazeutika)
Non-Executive Chairman 2023
Evozyne Inc Executive Chairman -
Paragon Pharmaceuticals Capital LLC Chairman & Chief Executive Officer 2010
Emalex Biosciences, Inc. Chairman & Chief Executive Officer -
Paragon Biosciences LLC Chairman & Chief Executive Officer 2010
Castle Creek Biosciences, Inc. Chairman 2018
Innovation Development Institute, Inc. Chairman -
Paragon Health Capital LLC Founder & Chairman 2019
Paragon Biosciences Emalex Capital, Inc. Director -
CIRC Biosciences, Inc. Director -
Skyline Biosciences LLC Director -
Qlarity Imaging LLC Director -
Paragon Biosciences Qlarity Capital, Inc. Director -
Paragon Biosciences Skyline Capital LLC Director & Manager -
Harmony Biosciences LLC Director -
Ravinia Festival Association Trustee -
Pharmaceutical Research & Manufacturers of America Director 2010
The Commercial Club of Chicago Director -
Weizmann Institute of Science Director -
The Aspen Institute, Inc. Director -


Anteile an Jeffrey S. Aronin 
NameAktien%Bewertung
Discover Financial Services (DFS)
(Banken)
17 6970,0071%1 593 969 USD
Harmony Biosciences Holdings, Inc. (HRMY)
(Pharmazeutika)
00,0000%0 USD


Jeffrey S. Aronin: Pers÷nliches Netzwerk 
Meistgelesene Nachrichten 
29.09.Elon Musk mischt sich an der texanisch-mexikanischen Grenze in die US-Einwanderungsdebatte ein
MR
20.09.Gehirnchip-Firma von Elon Musk startet klinische Studie
RE
21.09.Rupert Murdoch tritt als Vorsitzender von Fox und News Corp zurück
MR
29.09.Berichte - Allianz-Finanzchef Terzariol wechselt zu Generali
RE
26.09.Ermittler: Ex-Wirecard-Vorstand Marsalek in Spionage verwickelt
DP
21.09.Thailands neuer Premierminister trifft Tesla-Chef Musk in New York
MR
29.09.VW beerdigt Diess-Projekte - Belegung der Werke neu geordnet
DP
02.10.Allianz-Finanzvorstand wechselt zum Rivalen Generali
RE
19.09.Studie: Gründer von Heckler & Koch waren in Nazizeiten Mitläufer
DP
21.09.Karriereende mit 92 Jahren - Medienmogul Rupert Murdoch tritt ab
RE
Mehr B÷rsen-Nachrichten


© 2023 People and Ownership :   
Jeffrey S. Aronin : Verbindungen 


Die besten Tools - exklusiv fŘr unsere Abonnenten - um die Performance Ihrer Investitionen zu steigern!Meine Gewinne optimieren
Meine Gewinne optimieren